Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication

• click to rate

  Posted by Two Blokes May 23, 2025 - Filed in Stock - 5 views
  
  FDA approves RHHBY's Susvimo for diabetic retinopathy, its third indication, offering 9-month relief with one treatment.